Opposing Effects of Circadian Clock Genes Bmal1 and Period2 in Regulation of VEGF-Dependent Angiogenesis in Developing Zebrafish  by Jensen, Lasse Dahl et al.
Cell Reports
ReportOpposing Effects of Circadian Clock Genes Bmal1
and Period2 in Regulation of VEGF-Dependent
Angiogenesis in Developing Zebrafish
Lasse Dahl Jensen,1,3 Ziquan Cao,3 Masaki Nakamura,1 Yunlong Yang,1 Lars Bra¨utigam,2 Patrik Andersson,1 Yin Zhang,1
Eric Wahlberg,3 Toste La¨nne,3 Kayoko Hosaka,1 and Yihai Cao1,3,*
1Department of Microbiology, Tumor and Cell Biology
2Department of Medical Biochemistry and Biophysics, Division of Biochemistry
Karolinska Institute, 171 77 Stockholm, Sweden
3Department of Medicine and Health Sciences, Linko¨ping University, 581 85 Linko¨ping, Sweden
*Correspondence: yihai.cao@ki.se
http://dx.doi.org/10.1016/j.celrep.2012.07.005SUMMARY
Molecular mechanisms underlying circadian-
regulated physiological processes remain largely
unknown. Here, we show that disruption of the
circadian clock by both constant exposure to light
and genetic manipulation of key genes in zebrafish
led to impaired developmental angiogenesis. A
bmal1-specific morpholino inhibited developmental
angiogenesis in zebrafish embryos without causing
obvious nonvascular phenotypes. Conversely, a
period2 morpholino accelerated angiogenic vessel
growth, suggesting that Bmal1 and Period2 display
opposing angiogenic effects. Using a promoter-
reporter system consisting of various deleted vegf-
promoter mutants, we show that Bmal1 directly
binds to and activates the vegf promoter via E-boxes.
Additionally, we provide evidence that knockdown of
Bmal1 leads to impaired Notch-inhibition-induced
vascular sprouting. These results shed mechanistic
insight on the role of the circadian clock in regulation
of developmental angiogenesis, and our findings
may be reasonably extended to other types of phys-
iological or pathological angiogenesis.
INTRODUCTION
In mammals and other vertebrates, the circadian clock plays
a central role in regulation of physiological functions of almost
all tissues and organs (Panda et al., 2002; Sehgal and Mignot,
2011). It is known that some crucial genes involved in regulation
of cell growth, differentiation, and survival are tightly regulated by
the clock genes (Hunt and Sassone-Corsi, 2007). Owing to the
key importance of the circadian clock, certain transcription
factors, such as Bmal1 and Clock, and transcription coregula-
tors Period2 and Cryptochrome, or their homologs specialized
for circadian regulation of targeted genes, are widely present in
vertebrates, eukaryotic cells, and even prokaryotic cells (Schultz
and Kay, 2003). As such, disruption of the circadian clock maylead to the onset, development, and progression of certain
diseases, including neuronal disorders, metabolic disorders,
chronic inflammation, and even cancer (Allada, 2003). Therefore,
understanding the molecular mechanisms that control the circa-
dian clock is pivotal for prevention and treatment of these
common human diseases.
Angiogenesis is an essential process for embryonic develop-
ment and for maintenance of certain physiological functions in
the adult (Folkman, 1995). For example, the female reproductive
cycle and wound healing are dependent on angiogensis. Under
pathological conditions, uncontrolled growth of new blood
vessels could lead to the onset and development of diseases.
Tumor growth andmetastasis are dependent on neovasculariza-
tion, and targeting pathological blood vessels in tumors has
been demonstrated as an effective approach for cancer therapy
in human patients (Cao and Langer, 2010; Folkman, 2007; Kerbel
and Folkman, 2002). Additionally, antiangiogenic therapy has
produced remarkably beneficial effects on vision improvement
in patients with age-related macular degeneration (Stone, 2006).
Angiogenesis is regulated by both positive and negative
factors, and the expression levels of these factors can be altered
under pathological conditions (Cao, 2009a, 2009b). It is generally
believed that an angiogenic switch is turned on by tipping the
balance of angiogenic factors and inhibitors toward domination
of stimuli. Members of the vascular endothelial growth factor
(VEGF) family are the most well characterized, which include
VEGF (also called VEGF-A), -B, -C, -D, and placental growth
factor (PlGF) (Cao, 2009a). These angiogenic factors bind to
three tyrosine kinase (TK) receptors, VEGFR-1, VEGFR-2, and
VEGFR-3 expressed on the surface of blood or lymphatic vessel
endothelial cells to exert their biological functions (Caunt et al.,
2008; Pan et al., 2007; Soker et al., 1998). It is generally believed
that VEGFR-2 is the functional receptor that transduces angio-
genic and vascular permeability signals in response to VEGF
stimulation. In contrast to VEGFR-2, the function of VEGFR-1
remains poorly understood, and it may act as a decoy receptor
for the VEGF-triggered signaling (Cao, 2009a; Eriksson et al.,
2002). The Dll4-Notch signaling system has recently been
reported to restrict vascular sprouting and to modulate vascular
remodeling and maturation (Hellstro¨m et al., 2007; Noguera-
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2007). These functions are tightly associated with modulation of
the VEGF-induced angiogenic activity. Inhibition of Dll4 or the
Notch receptor signaling system leads to an increased number
of vascular sprouts in tumors and other tissues (Cao et al.,
2008; Noguera-Troise et al., 2006).
Despite the vast knowledge of circadian biology and angio-
genesis, the role of the circadian clock in regulation of angiogen-
esis and vascular patterning remains poorly understood. In the
present study, we use developing zebrafish embryos to demon-
strate the crucial role of the circadian clock in controlling
vascular network formation and patterning. Our findings may
imply novel therapeutic options for the treatment of angiogen-
esis-dependent diseases, such as cancer and cardiovascular
diseases, by targeting the circadian clock.
RESULTS
Exposure to Constant Light, but Not Constant Darkness,
Impairs Vascular Development
To study the impact of the circadian clock on vascular develop-
ment, Tg(Fli1:egfp) zebrafish (Lawson and Weinstein, 2002)
embryos at the age of 1 hr postfertilization (hpf) were exposed
to constant cold-light (LL,1800 lux), constant darkness (DD), or
a 12 hr light-dark (LD) cycle. Under identical conditions except
the light source, LL-exposure neither affected the zebrafish
viability nor caused any abnormal phenotypes (Figure 1A).
Similarly, DD exposure did not result in any morphological
changes of developing zebrafish. Notably, the somite length
and the head angles, two widely used parameters for staging
the development of zebrafish embryos (Kimmel et al., 1995),
were virtually identical in LL- or LD-exposed zebrafish embryos
(Figure 1B). These findings indicate that LL-exposure is well
tolerated by zebrafish embryos. At 24 hpf under constant light
exposure, development of intersegmental vessels (ISVs) was
significantly impaired relative to those embryos exposed to LD
(Figure 1C). Quantification analysis showed that the average
length of ISVs in LL-exposed zebrafish embryoswas significantly
shorter relative to those embryos exposed to LD (Figure 1D).
Similar to ISVs, exposure of zebrafish embryos to LL until
72 hpf led to significantly decreased development of subintesti-
nal veins (SIVs, Figures 1C and 1D). In contrast to LL, DD
exposure did not result in significant alterations of ISVs or SIVs
as compared to LD exposure (Figures 1C and 1D). These
findings demonstrate that LL exposure significantly impairs
developmental angiogenesis in zebrafish.
To study the impact of LL and DD exposure in modulation of
period2, a known clock gene to be affected by light (Vatine
et al., 2009), period2 expression levels were quantitatively
analyzed using an RT-PCR method. As expected, period2
expression under LD conditions exhibited circadian rhythmicity,
being upregulated during light exposure and downregulated
during the dark phase (Figures 1E and 1F). Interestingly, DD
exposure led to marked regression of period2 expression levels,
which were barely detectable at the various hpf time points.
Conversely, LL exposure resulted in persistent upregulation of
period2 (Figures 1E and 1F). These findings demonstrate that
exposure of zebrafish embryos to LL and DD could lead to
differential expression of the clock gene period2.232 Cell Reports 2, 231–241, August 30, 2012 ª2012 The AuthorsOpposing Effects of Bmal1 and Period2
on Developmental Angiogenesis
To further delineate the role of the circadian clock in regulation of
developmental angiogenesis, we utilized the morpholino tech-
nology to interrupt the circadian clock in zebrafish embryos by
knocking down expression of some critical circadian genes,
including bmal1, bmal2, period2, and clock3 (Allada, 2003).
These morpholinos have previously been shown to impair pineal
gland development (Appelbaum et al., 2005; Triqueneaux et al.,
2004; Vatine et al., 2009; Ziv et al., 2005). As the pineal gland
serves as a master circadian pacemaker, disruption of its devel-
opment by thesemorpholinoswould have a significant impact on
the circadian clock as a whole. To demonstrate that these
morpholinos sufficiently blocked translation of their correspond-
ing clock gene products, zebrafish cDNAs coding for clock
genes, including bmal1, bmal2, clock3, and period2, were
cloned into a pCS2-C-myc vector, which allowed generation of
fusion proteins with a myc-tag. The in vitro-transcribed mRNAs
were injected with or without morpholinos into zebrafish
embryos. As shown in Figure S1, bmal1, bmal2, clock3, and
period2 morpholinos effectively blocked translation of injected
corresponding mRNA in zebrafish embryos as detected by
an anti-myc-tag antibody. These data demonstrate that the
morpholinos used in our study efficiently knocked down their
corresponding clock gene products.
Interestingly, injection of the bmal1morpholino at the one-cell
stage of developing zebrafish embryos under LD led to marked
repression of ISV development compared to scrambled or
mismatch bmal1morpholinos (Figures 2A and 2B). Downregula-
tion of the Bmal1 function by the specific morpholino resembled
the LL-induced vascular impairment (Figure 1). Surprisingly,
knockdown of Period2 under LD conditions did not suppress
vascularization but unexpectedly enhanced ISV growth as
compared with the mismatch morpholino control (Figures 2A
and 2B). These findings suggested that Bmal1 and Period2might
display opposing effects on embryonic vessel development
under the LD physiological condition. Morpholinos specifically
targeting bmal2 and clock3 were also tested in the same exper-
imental setting. In contrast to bmal1 and period2 morpholinos,
delivery of bmal2 or clock3 morpholinos to zebrafish embryos
did not significantly affect ISV development (Figures 2A and
2B). Similarly, a combination of bmal1 and bmal2 morpholinos
did not produce any additive effects as compared with bmal1
morpholino alone (Figures 2A and 2B).
To gain further molecular information on the LL-induced
vascular impairment in relation to circadian genes, Bmal1-
knock-down zebrafish embryos were exposed to LL. Intrigu-
ingly, knockdown of Bmal1 followed by LL exposure did not
produce an additive effect on the impairment of ISVs, suggesting
that downregulation of Bmal1 mediates LL-induced vascular
retardation (Figures 2A–2C). Conversely, knockdown of Period2
under LL exposure completely rescued the LL-induced vascular
defects on ISV development (Figures 2A–2C), validating the
negative role of Period2 in regulation of vascular development.
Indeed, quantitative real-time PCR (qPCR) analysis demon-
strated that period2 was markedly upregulated at 48 and
72 hpf under LL exposure (Figure 2I). Taken together, these
findings demonstrate that Bmal1 acts as a positive mediator
Figure 1. Constant Light Exposure Inhibits Developmental Angiogenesis
Tg(Fli1:EGFP)y1 transgenic zebrafish embryos exposed to LD (A–D), LL (A–D), or DD (C and D) were examined for ISV development at 24 hpf (C and D) or for SIV
development at 72 hpf (C and D) using confocal microscopy.
(A) Morphology of zebrafish embryos was examined at 24 hpf and 48 hpf under LD and LL conditions.
(B) Average ± SEM somite lengths and head angles were quantified under LD and LL conditions (n = 7–9/group).
(C) Zebrafish embryos were raised under LD, DD, or LL conditions from 1 hpf. Dashed lines indicate the maximal length of ISVs. Yellow dashed lines encircle the
SIV. Scale bar for ISV is 50 mm and for SIV is 100 mm.
(D) Quantification of the average ± SEM. ISV length (n = 52–54 embryos/group) of 24 hpf embryos and the SIV area of 72 hpf embryos (n = 48 embryos).
(E) RT-PCR analysis of average zebrafish period2 (P2) expression ± SEM under LD, LL, and DD conditions (a pooled sample of 25 zebrafish embryos/group).
(F) Densitometric quantification of average period2 expressions shown in (E).
Bars in (A) = 500 mm. S, somite; NC, notochord; H, hindbrain; M, mesencephalon; E, eye. Blue lines in (A) indicate the head angle. *p < 0.05 and **p < 0.01. NS, not
significant.
See also Figure S2.for vascular development, whereas Period2 negatively regulates
angiogenesis.
Similar to LL exposure, neither bmal1 nor period2morpholinos
caused nonvascular defects, including changes in the somite
development and the head angles (Figures 2D–2E). The vascular
specific effects of bmal1 and period2 morpholinos were further
validated using other specific organ or tissues markers. In situ
hybridization showed that expression of sonic hedgehog (shh),
a key morphogen during organogenesis and expression ofacetylated alpha tubulin, a marker for axon maturation and
stability was not altered (Figure S2).
Restoration of LL- or bmal1 Morpholino-Induced ISV
Defects by bmal1 mRNA
To further validate the role of Bmal1 and Period2 inmodulation of
ISV development, we performed gain-of-function experiments
by injection of zebrafish bmal1 or period2 mRNA under various
conditions. As expected, injection of bmal1 mRNA resulted inCell Reports 2, 231–241, August 30, 2012 ª2012 The Authors 233
Figure 2. Opposing Roles of Bmal1 and Period2 in Regulation of Developmental Angiogenesis
(A) Zebrafish embryos received injections of specificmorpholinos targeting Bmal1 (B1MO), Bmal2 (B2MO), Clock3 (C3MO), or Period2 (P2MO) (0.2 pmol/embryo)
and were subsequently raised under LL or LD conditions. Scrambledmorpholino (scrMO), five base-pair mismatch bmal1 (B1misMO), or five base-pair mismatch
period2 (P2misMO) were used as controls. Dashed lines indicate the maximal length of ISVs. Bar = 50 mm.
(B) Quantification of the average length ± SEM of ISVs in 24 hpf embryos under the LD condition (n = 8–48 embryos/group).
(C) Quantification of the average length ± SEM of ISVs in 24 hpf embryos under the LL condition (n = 6–37 embryos/group).
(D) Morphology of zebrafish embryos was examined at 24 hpf and 48 hpf under LD and LL conditions. Bars = 500 mm. S, somite; NC, notochord; H, hindbrain;
M, mesencephalon; E, eye.
(E) Quantification of average ± SEM somite lengths and head angles under LD and LL conditions (n = 7–17/group).
(F) Zebrafish embryos received injections of specific morpholinos targeting Bmal1 (B1MO), Period2 (P2MO), scrambled morpholino (scrMO), bmal1 mRNA
(B1mRNA), period2 mRNA (P2mRNA), B1mRNA plus B1MO, or P2mRNA plus P2MO and were subsequently raised under LD or LL conditions. Dashed lines
indicate the maximal length of ISVs. Bar = 50 mm.
(G) Quantification of the average length ± SEM of ISVs in 24 hpf embryos under the LD condition (n = 8–27 embryos/group).
(H) Quantification of the average length ± SEM of ISVs in 24 hpf embryos under the LL condition (n = 6–28 embryos/group).
(I) qPCR of average ± SEM period2 mRNA expression levels after 48 or 72 hpf LD or LL exposure (n = 3–4 3 20–50 embryos/group). *p < 0.05; **p < 0.01; and
***p < 0.001. NS, not significant.
See also Figures S1 and S2.
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a significant increase of ISV length (Figures 2F–2H). Intriguingly,
sequential injection of bmal1 morpholino followed by bmal1
mRNA significantly restored ISV development (Figures 2F and
2G). Similarly, delivery of bmal1 mRNA completely rescued
the LL-induced ISV defects (Figures 2F–2H). Conversely, admin-
istration of period2 mRNA significantly antagonized the period2
morpholino-induced vessel growth (Figures 2F and 2H). These
findings demonstrate that the morpholinos used in our study
were specific for bmal1 and period2 and further validate the
vascular role of these clock genes.
VEGF Mediates Bmal1-Induced Angiogenesis
VEGF is a key angiogenic factor during embryonic development
and in pathological conditions, including tumor growth and
ophthalmological disorders (Ferrara et al., 2003; Nagy et al.,
2007). In mice, heterozygous deletion of the vegf gene leads to
early embryonic lethality owing to lack of vascular and hemato-
poietic development, demonstrating that an optimal level of
VEGF is essential to ensure appropriate development of various
tissues and organs (Carmeliet et al., 1996; Ferrara et al., 1996).
To study the involvement of VEGF and its receptor signaling
system in mediating circadian-modulated angiogenesis, a
specific vegf morpholino (Nasevicius et al., 2000) was used in
combination with bmal1 or period2 morpholinos. As expected,
delivery of a high dose of vegf morpholino (0.2 pmol/embryo)
to zebrafish embryos resulted in virtually complete suppression
of ISV growth at 24 hpf (Figure 3B), suggesting that VEGF is
absolutely required for ISV development. However, injection of
a low dose of vegf morpholino (0.06 pmol/embryo) led to an
only partial but statistically significant inhibition of ISV develop-
ment (Figures 3A and 3C). Interestingly, a combination of vegf
and bmal1morpholinos additively inhibited ISV growth, whereas
coinjection of vegf and period2 morpholinos did not result in an
additional inhibitory effect but a slightly increased angiogenic
response (Figures 3A and 3C).
Similar to the vegf morpholino, addition of an orally active
VEGFR tyrosine kinase inhibitor (ZN323881, TKI) (Cao et al.,
2008) to the aquarium water at a low concentration resulted in
partial suppression of ISV development (Figures 3A and 3C).
Again, delivery of a combination of ZN323881 and the bmal1
morpholino resulted in an additive effect on suppression of the
ISV growth (Figures 3A and 3C). Conversely, a combination of
ZN323881 and period2 did not further potentiate the inhibitory
activity as compared with ZN323881 alone. An independent
experiment using sunitinib, another orally active VEGFR TKI,
produced virtually identical results (Figure S3).
Bmal1 Targets the vegf Promoter for Transcriptional
Activation
To provide direct evidence that the vegf gene is a direct target for
Bmal1, a vegf promoter-luciferase reporter system was used to
study regulation of vegf promoter activity by the circadian clock
in zebrafish embryos. A bmal1 promoter-luciferase reporter
system was also constructed to measure alteration of the
Bmal1 level by the circadian clock. We used both human and ze-
brafish vegf promoter-luciferase in our studies. Intriguingly, an
almost perfect coordination of expression patterns was
observed between human VEGF and mouse Bmal1 under LDexposure (Figure 3G), suggesting that VEGF expression levels
are modulated by the circadian clock. Strikingly, the correlation
between bmal1 and vegf promoter activity was disrupted under
LL conditions (Figure 3G). Inversely, bmal1 and vegf promoter
activity coincided and exhibited circadian rhythmicity under DD
conditions (Figure 3G).
Similarly, zebrafish vegf promoter activity was also coordi-
nately regulated by the circadian clock under LD and DD con-
ditions (Figure 3H), and LL-exposure significantly suppressed
zebrafish vegf promoter activity (Figure 3D). To validate these
findings, we measured the endogenous levels of bmal1 and
vegf mRNA in zebrafish using a qPCR method. In principle, the
circadian expression pattern of bmal1 matched that of vegf
under LD exposure (Figure 3I). Particularly, endogenous expres-
sion levels of zebrafish bmal1 and vegf exhibited coordinated
rhythmicity even during prolonged LD exposure (Figures S4A
and S4B). These findings provide compelling evidence that
VEGF coincides with Bmal1 expression under LD conditions.
Again, LL exposure almost completely ablated the rhythmic
expression of vegf and bmal1 genes (Figure 3I), indicating that
expression levels of bmal1 and vegf are tightly regulated by the
circadian clock. Similar to LD conditions, zebrafish embryos
under DD exposure retained the rhythmicity of bmal1 and vegf
expression (Figure 3I).
As an independent proof of the intimate interaction between
Bmal1 and VEGF expression, knockdown of Bmal1 led to signif-
icantly decreased levels of human and zebrafish VEGF expres-
sion (Figures 3E and 3F), demonstrating that Bmal1 is required
to maintain a steady-state level of VEGF expression. These find-
ings provide a mechanistic insight that Bmal1 might directly
target the vegf promoter for transcriptional regulation.
To study if Bmal1 directly targets the vegf promoter, we
analyzed the promoter regions of the vegf genes in zebrafish,
mice, and humans. In zebrafish, we identified four confirmed
E-box regions that potentially bind to the Bmal1-transcription
complex (Figures 3J and 3K). There were totally five such
Bmal1-binding E-boxes on the promoter region of the mouse
vegf gene and one exist in the promoter region of the human
vegf gene (Figure 3J). In addition, multiple unconfirmed Bmal1-
binding E-boxes exist in all three species and these E-box sites
are likely to bind to Bmal1. To study if E-boxes in the zebrafish
VEGF promoter are involved in Bmal1-regulated VEGF expres-
sion, a series of E-box-deleted mutants of the promoter was
generated (Figure 3K). Deletion of E-box 1 resulted in significant
reduction of the zvegf promoter activity (Figures 3K and 3L).
Similarly, deletion of the cluster E-boxes 2–4 virtually completely
abolished the zvegf promoter activity (Figures 3K and 3L). These
findings demonstrate that E-boxes in the zvegf promoter are
essentially required for transcriptional regulation of VEGF
expression. We next performed a chromatin immunoprecipita-
tion assay in which an anti-mouse Bmal1 antibody was used to
precipitateBmal1protein using amousecell line. The crosslinked
DNA-protein complexes were then disassociated and PCR
amplified using several pairs of specific primers covering various
regions of the vegf promoter. An E-box-less vegf fragment was
used as a negative control, and a fragment containing the first
two E-boxes in the period1 gene was used as a positive control
as previously described (Jung et al., 2003). As expected,Cell Reports 2, 231–241, August 30, 2012 ª2012 The Authors 235
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fragments containing E-boxes 1–3 and 4–5 in the vegf promoter
region showed direct binding to Bmal1 (Figure 3M), whereas
the E-box-less fragment did not show significant binding activity.
Taken together, these results provide compelling evidence that
Bmal1 directly binds to the vegf promoter via E-boxes.
Relation of Circadian and Notch Signaling in Regulation
of Vessel Development
To study the involvement of the Notch signaling system inmodu-
lation of the circadian clock-VEGF axis, three independent
approaches were used to block the Notch pathway. First, a
g-secretase inhibitor (DAPT) that inhibits the Notch signaling
system was used. As expected, addition of DAPT to the
aquarium water resulted in the formation of high-density
vascular networks and a high number of vascular braches from
ISVs (Figures 4A and 4B). Second, we designed a morpholino
specifically targeting recombining binding protein suppressor
of hairless (rbpsuh) (Siekmann and Lawson, 2007) that mediates
the Notch signaling. Similar to DAPT, delivery of the rbpsuhmor-
pholino also led to the formation of a disorganized ISV network
that consisted of a high density of microvessels that grew in
widely different directions (Figures 4A and 4B). Finally, a genetic
mutant strain of zebrafish that lacks functional mind-bomb,
a ubiquitin ligase involved in mediating the Notch signaling
(Haddon et al., 1998), was used. Again, a high degree of ISV
malformation and excessive vascular braches/sprouts existed
in the mind-bomb mutant zebrafish (Figures 4A and 4B). These
findings provide compelling evidence that inhibition of the Notch
signaling system leads to the formation of a high density of
disorganized vascular networks in the ISV region.
Interestingly, delivery of the bmal1 morpholino to zebrafish
embryos markedly reduced the Notch inhibition-induced
vascular malformation and excessive vascular sprouts (Figures
4A and 4B). Inversely, the period2 morpholino did not signifi-
cantly affect the Notch inhibition-induced vascular phenotypeFigure 3. Circadian Clock Regulates Expression Levels of VEGF
(A) Zebrafish embryos were injected with scrambled (scrMO) morpholino (A) or
combinations with bmal1 (B1MO) or period2 (P2MO) morpholinos (0.2 pmol/emb
VEGFR TKI (0.3 mM ZN323881) alone or in combinations with bmal1, period2, or
raised under the LD condition.
(B) High doses of the vegf morpholino (0.2 pmol/embryo) or ZN323881 (1.0 mM)
the maximal length of ISVs in various groups. Bars = 50 mm. Quantification of the
(C) Quantification of the average ISV length ± SEM in 24 hpf embryos from the e
(D) Zebrafish vegf promoter activity as measured by average luciferase activity ±
(E) Zebrafish vegf promoter activity in scrambled or bmal1 morpholino-treated z
embryos/group).
(F) Human vegf promoter activity in scrambled or bmal1 morpholino-treated ze
embryos/group).
(G–H) Values of average relative luciferase activity ± SEM in embryos exposed to
human vegf promoter-luciferase (G) or zebrafish vegf promoter-luciferase (H). R
mouse bmal1 promoter-luciferase reporter plasmid.
(I) qPCR analysis of average ± SEM endogenous levels of bmal1 (red line) and ve
(J) Sequence analysis of human, mouse, and zebrafish vegf promoter regions tha
binding E-boxes, and white boxes represent unknown binding E-boxes.
(K) Schematic diagram showing various deleted mutants of the zebrafish vegf pr
(L) Average luciferase activity ± SEM in embryos injected with various deleted mu
LD exposure (n = 20 embryos/group).
(M) ChIP assay of average Bmal1 binding ± SEM to the zebrafish vegf promoter.
See also Figures S3 and S4.(Figures 4A and 4B). Administration of the vegf morpholino at
a low dose to zebrafish embryos partly prevented the Notch
inhibition-induced vascular phenotypes (Figures 4A and 4B),
suggesting that VEGF mediates the Notch-induced vascular
changes. As described above, expression levels of VEGF and
Bmal1 were downregulated under the LL condition. Under LL
exposure, the Notch inhibition-induced vascular malformation
was partially prevented (Figures 4C and 4D). On the contrary,
knockdown of Period2 under LL further potentiated the Notch
inhibition-induced vascular phenotype (Figures 4C and 4D).
These findings suggest that the circadian clock-regulated
VEGF expression levels act as a driving force for the Notch-
induced vascular changes.
DISCUSSION
The circadian clock controls growth, migration, differentiation,
and survival of many cell types and is involved in regulation of
physiological and pathological processes, such as embryonic
and disease development. Angiogenesis is required for embry-
onic development and excessive or defective blood vessel
growth has been linked to various human diseases (Cao,
2009a; Cao et al., 2011). However, the role of the circadian clock
in regulation of angiogenesis under physiological and patholog-
ical conditions remains poorly understood. Using zebrafish as an
in vivo model, we, in the present study, provide compelling
evidence that developmental angiogenesis is tightly controlled
by the circadian clock. At the molecular level, we showed that
Bmal1 and Period2 displayed opposing effects on vascular
development via regulation of VEGF expression. The circadian
clock-regulated VEGF levels crosstalk with the Notch signaling
system in controlling the extent of vessel sprouts and functions.
Although the study was performed in zebrafish, our data may be
reasonably extended to mammals, including humans because
the clock genes are highly conserved among these species.a low dose of the vegf morpholino (VEGFMO, 0.06 pmol/embryo) alone or in
ryo). Some embryos were treated with either DMSO vehicle or a low dose of
scrambled morpholinos (0.2 pmol/embryo). The embryos were subsequently
were also delivered to zebrafish embryos. Dashed lines in (A and B) indicate
average ISV length ± SEM in 24 hpf embryos (n = 12–68 embryos/group).
xperiment shown in (A) (average n = 36 embryos/group).
SEM in zebrafish embryos exposed to LD or LL (n = 20 embryos/group).
ebrafish embryos as measured by average luciferase activity ± SEM (n = 20
brafish embryos as measured by average luciferase activity ± SEM (n = 20
LD, LL, or DD. Black line: Luciferase activity in zebrafish embryos injected with
ed lines in G represent luciferase activity in zebrafish embryos injected with a
gf (black line) under LD, LL, and DD conditions.
t contain E-boxes that bind to Bmal1. Red boxes represent the known Bmal1
omoter region. ptr, promoter.
tants of the zebrafish vegf promoter-luciferase and subsequently raised under
EB, E-box. *p < 0.05; **p < 0.01; and ***p < 0.001. NS, not significant.
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Figure 4. Involvement of the Notch Signaling Pathway in Circadian Clock-Regulated Vascular Sprouting
(A) Zebrafish embryos received bmal1 (B1MO, 0.2 pmol/embryo), period2 (P2MO, 0.2 pmol/embryo) or vegf (VEGFMO, 0.1 pmol/embryo) morpholinos, either
alone or in combination with DAPT (100 mM), rbpsuh morpholino (RbpsuhMO, 0.1 pmol/embryo), or in the mind-bomb background. The embryos were
subsequently raised under the LD condition. Arrows point to ISV braches in each group. Scale bar is 100 mm.
(B) Quantification of the average ± SEM. ISV density or number of branches/segment of 72 hpf embryos in (A) (average n = 23 embryos/group).
(C) Zebrafish embryos received period2 (P2MO, 0.2 pmol/embryo) alone or in combination with DAPT (100 mM), rbpsuh morpholino (RbpsuhMO,
0.1 pmol/embryo), or in the mind-bomb background. The embryos were subsequently raised under LD or LL conditions. Arrows point to ISV braches in each
group. Scale bar is 100 mm.
(D) Quantification of the average ± SEM. ISV density or number of branches/segment of 72 hpf embryos in (C) (average n = 23 embryos/group). *p < 0.05;
**p < 0.001; and ***p < 0.001. NS, not significant.During embryogenesis, vascular development is tightly regu-
lated by various positive and negative regulators. Optimal
levels of these vascular modulators are essential to ensure the
formation of healthy and functional vascular networks that
perfuse sufficient O2 and nutrients for tissue and organ develop-
ment (Carmeliet et al., 1996; Ferrara et al., 1996; Gale et al.,
2004). Inadequate expression levels of key angiogenic factors
might lead to the malformation of blood vessels, which eventu-
ally terminates development of the entire embryo. For example,
genetic deletion of only one allele of the vegf gene or the dll4
gene in mice (haploinsufficiency) leads to early embryonic death
owing to vascular defects (Carmeliet et al., 1996; Ferrara et al.,
1996; Gale et al., 2004). These studies suggest that an optimal
level of VEGF is absolutely required for proper vascular develop-
ment, navigation of vessel outgrowth, and maintenance of
vascular functions. The VEGF expression level can bemodulated238 Cell Reports 2, 231–241, August 30, 2012 ª2012 The Authorsby multiple factors in tissue microenvironments. For example,
tissue hypoxia potently upregulates VEGF expression (Boutin
et al., 2008; Makino et al., 2001). In this study, we have shown
that the circadian clock directly modulates VEGF expression
levels via transcriptional regulation during embryonic develop-
ment. First, we show that VEGF expression in developing
embryos exhibits a clear circadian rhythm. Second, the VEGF
expression pattern almost completely matches the expression
pattern of Bmal1, which is an essential component of the
circadian clock-induced gene expression program. Third, we
provide molecular evidence that the vegf promoter contains
several Bmal1 binding E-boxes and that Bmal1 directly binds
to the vegf promoter via these E-boxes. Finally, we showed
that knockdown of Bmal1 directly reduced the vegf promoter
activity using a luciferase reporter system in whole zebrafish
embryos. These data provide convincing evidence that the
circadian clock directly regulates VEGF expression and vascular
development.
One of our intriguing findings is that LL and DD exposure leads
to differential regulation of some clock genes, although both
conditions are known to disrupt the circadian clock. This inter-
esting finding is discussed in more detail in the Extended
Discussion.
The implication of our findingsmight be extended to regulation
of angiogenesis under pathological conditions. For example, it is
known that disruption of the circadian clockmay increase cancer
incidence (Hrushesky et al., 1999; Stevens et al., 2011). It is plau-
sible that the circadian clock-regulated VEGF expression and
vascular development might significantly contribute to tumor
development. This possibility warrants further investigation.
Another interesting finding of our study is the relation between
the circadian clock-modulated VEGF levels and the Notch
signaling-induced vascular remodeling. Notch signaling restricts
vascular sprouts by limiting endothelial tip cell formation and
maintaining arterial identity, which is dependent on its relation
to VEGF (Noguera-Troise et al., 2006; Ridgway et al., 2006).
VEGF is the driving force of tip cell formation, vascular sprouting
and the formation of primitive vascular networks. We showed
that downregulation of VEGF expression by interruption of the
circadian clock or knocking down Bmal1 leads to an abridged
effect of Notch inhibition-induced vascular malformation. Inter-
estingly, inhibition of NADPH oxidases is associated with down-
regulation of Dll4 and Notch signaling (Bhandarkar et al., 2009).
This signaling system in relation to the circadian clock warrants
further study.
Despite vascular defects under circadian clock-disrupted
conditions, zebrafish developmentwas not significantly affected.
Unlike mammals, zebrafish embryos undergo persistent devel-
opment for approximately 1 week in the absence of vasculature
or circulation (Stainier et al., 1995). These avascular zebrafish
embryos are dependent on free diffusion of oxygen andnutrients.
Also, compensatorymechanismsmay exist in zebrafish because
of the many clock gene homologs. For example, three Bmal,
three Clock, four Period, and six Cryptochrome homologs have
been reported to exist in zebrafish (Wang, 2008a, 2008b, 2009),
and they may have redundant and distinct functions. In the
present study, we provide an example of opposing vascular
functions of Bmal1 and Period2. Unlike Bmal1 and Period2,
knockdown of Bmal2 or Clock3 did not cause any obvious
phenotypes. Additionally, several other clock gene products,
including Clock1, Clock2, and Period3, were investigated using
the morpholino approach. The phenotypes of Clock1-, Clock2-,
andPeriod3-deficient zebrafish embryos are under investigation.
Taken together, our data provide mechanistic insight on circa-
dian clock-regulated vascular development. Maintenance of the
normal circadian clock would be essential to ensure proper
development of vasculatures in the embryos and probably in
other physiological and pathological conditions.EXPERIMENTAL PROCEDURES
Zebrafish Strains and Husbandry
Zebrafish of the Tg(fli1:EGFP)y1 and Tg(Mibta52b/ta52b;fli1:EGFP)y1 strains
(ZFIN, Eugene, OR, USA) were used in this study, as previously described(Cao et al., 2010; Rouhi et al., 2010). All experiments were performed in accor-
dance with ethical permissions granted by the North Stockholm Experimental
Animal Ethical Committee, Sweden.
Morpholino Treatment
All morpholinos used in this study were purchased from Gene Tools
(Philomath, OR, USA).
Assessment of Morpholino Efficiency
Amplified fragments of the bmal1a, bmal2, period2, and clock3 open reading
frames were cloned into the pCS2-C-Myc vector to generate C-terminal
myc-tag fusion constructs. Myc-fusion proteins were detected in the presence
or absence of morpholino by immunohistochemistry with a 9E10 monoclonal
anti-myc antibody (Sigma-Aldrich, St. Louis, MO, USA).
RT-PCR
Total RNA was reverse-transcribed using a RevertAid H minus First Strand
cDNA Synthesis Kit (Fermentas, Glen Burnie, MD, USA). RT-PCR was
performed using DreamTaq Green PCR Master Mix (Thermo Scientific,
Waltham, MA, USA). See the Extended Experimental Procedures for a list of
primers used in this study. Bands were quantified by the densitometry function
of the Quantity One software.
Zebrafish VEGF-Luciferase Construction and Promoter Deletion
Promoter fragments of different sizes for the zebrafish vegfab gene was gener-
ated by PCR from zebrafish genomic DNA and cloned into the pGL3-Basic
vector (Promega, Madison, WI, USA).
Promoter Activity Assay
Zebrafish embryos were injected with human vegf promoter-luciferase, mouse
bmal1 promoter-luciferase, or zebrafish vegfab promoter-luciferase, followed
by immediate transfer to LD, LL, or DD conditions. The dual luciferase kit
(Vector Laboratories, Burlingame, CA, USA) was used for detection of
luciferase activity.
Quantitative Real-Time PCR
RNA purification was performed from whole embryos using a GeneJET RNA
purification kit (ThermoFisher Scientific). RNA levels of zebrafish genes were
detected by qPCR, as described previously (Xue et al., 2008).
Generation of Capped mRNA
Capped mRNA was prepared using the mMessage/Machine Kit (Ambion,
Austin, TX, USA). The full-length EST clone of Bmal1 (IMAGE 2643691) was
subcloned into pCS2+.
Chromatin Immunoprecipitation Assay
Mouse fibroblast cells were used for the EZ-ChIP chromatin immunoprecipita-
tion assay (Millipore, Billerica, MA, USA). A rabbit anti-Bmal1 antibody
(2.5 mg per sample; Abcam, Cambridge, UK) and a nonimmune rabbit IgG
(2.5 mg per sample; Millipore) were used for immunoprecipitation. The purified
DNA was used for qPCR analysis. See the Extended Experimental Procedures
for a list of primers used.
Zebrafish Histology
Zebrafish immunohistochemistry and in situ hybridization was performed
according to published protocols (Bra¨utigam et al., 2011) using antiacetylated
tubulin antibodies (Sigma-Aldrich cat no. T-6793; 1:1,000 dilution) and a cDNA
EST clone coding for zebrafish sonic hedgehog (Imagenes, SHH: IMAGE ID
9037826). Stained zebrafish were analyzed under a Leica MZ16 microscope
equipped with a Leica DFC300FX camera.
Microscopy and Imaging Analysis
Zebrafish embryos were whole-mounted in VectaShield (Vector) and exam-
ined under a confocal microscope (Nikon D-Eclipse C1), as previously
described (Dahl Ejby Jensen et al., 2009; Lee et al., 2009).Cell Reports 2, 231–241, August 30, 2012 ª2012 The Authors 239
Statistical Analysis
Statistical analyses were done using the standard two-tailed Student t test,
and *p < 0.05, **p < 0.01, and ***p < 0.001 were considered statistically signif-
icant. The n values indicate the number of individual embryos analyzed. Data
were presented as means ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes an Extended Discussion, Extended Exper-
imental Procedures, and four figures and can be foundwith this article online at
http://dx.doi.org/10.1016/j.celrep.2012.07.005.
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